Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
30.39
+0.92 (3.12%)
Jan 30, 2025, 4:00 PM EST - Market closed
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $3.78 billion as of January 30, 2025. Its market cap has decreased by -54.58% in one year.
Market Cap
3.78B
Enterprise Value
3.85B
1-Year Change
-54.58%
Ranking
Category
Stock Price
$30.39
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $3.78B, an increase of 447.02%. That is a compound annual growth rate of 26.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 727.70B |
| UnitedHealth Group | 500.19B |
| Novo Nordisk | 389.08B |
| Johnson & Johnson | 368.10B |
| AbbVie | 312.61B |
| Merck & Co. | 247.75B |
| Abbott Laboratories | 224.49B |
| Thermo Fisher Scientific | 223.24B |